Winning Stock Forecast: Arrowhead Pharmaceuticals (NASDAQ: ARWR) Returns up to 321.18% in 1 Year


Since the beginning of 2018 Arrowhead Pharmaceuticals showed growth catalysts for this year. First, according to the quarterly report for the period ended December 31, 2017, on September 28, 2016 the Company entered into a collaboration agreement with Amgen Inc. The Company received a worldwide license for ARO-AMG1, an RNAi therapy for an undisclosed genetically validated cardiovascular target, that makes Amgen wholly responsible for clinical development and commercialization of this technology. Moreover, the

Read More

Regeneron Stock Forecast: Bullish Long Term Buy For This Undervalued Stock


This article was written by Grant Goldstein, a Financial Analyst at I Know First



  • Regeneron has Underwhelming Q1 Financials
  • REGN is Undervalued
  • I Know First Bullish Forecast for REGN
I Know First.  

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Winning AVXL Stock Forecast: Life Changing Treatment Discoveries and M&A Expectations Add Value to Avanex

“We are looking forward, focusing on executing clinical trials using the inclusion of advanced genomic biomarkers into late-stage CNS precision medicine trials, including our Rett syndrome, Alzheimer’s disease and Parkinson’s disease dementia trials – all indications with high unmet need”

-Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.

Anavex Life Sciences Corp. (NASDAQ: AVXL) is a biopharmaceutical company focused on using genetic medicine to treat neurodegenerative and neurodevelopmental diseases, such as Alzheimer’s disease

Read More

Best Pharma Stocks Based On Algorithms: Up to 15.02% Returns in 7 days

Package Name: Pharma Package
Forecast Length: 7 Days (12/15/15 – 12/23/15)
I Know First Average: 8.06%

Read The Full Forecast

Best Pharmaceutical Stocks

Pharmaceutical Stocks To Buy Based On Genetic Algorithms: Up to 15.21% Returns in 14 days

Package Name: Pharma Package
Forecast Length: 14 Days (12/8/15 – 12/22/15)
I Know First Average: 4.68%

Read The Full Forecast

Pharmaceutical Stocks To Buy